Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies
Fudan University
Fudan University
Cedars-Sinai Medical Center
Boston Scientific Corporation
Next Biomedical Co., Ltd.
Centre Paul Strauss
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Hospices Civils de Lyon
City of Hope Medical Center
M.D. Anderson Cancer Center
Ramsay Générale de Santé
UNC Lineberger Comprehensive Cancer Center
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Ruijin Hospital
Cedars-Sinai Medical Center
Washington University School of Medicine
Pack Health
St. Borbala Hospital
Edwards Lifesciences
Cedars-Sinai Medical Center
Assistance Publique - Hôpitaux de Paris
Peking Union Medical College Hospital
Beijing Chao Yang Hospital
Fondazione Poliambulanza Istituto Ospedaliero
Hospital Universitario Virgen de la Arrixaca
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of California, San Diego
OncoSil Medical Limited
OncoSil Medical Limited
West China Hospital
Albert Einstein College of Medicine
Institut Cancerologie de l'Ouest
University of Arizona
Terumo Europe N.V.
Shanghai Zhongshan Hospital
AHS Cancer Control Alberta
University Hospital, Ghent
Rigshospitalet, Denmark
Ruijin Hospital
Hospital Moinhos de Vento
Centre Leon Berard
Asan Medical Center
Huazhong University of Science and Technology
Amsterdam UMC, location VUmc
Sunnybrook Health Sciences Centre
Roswell Park Cancer Institute
Technical University of Munich
Azienda Ospedaliera di Padova
Vrinnevi Hospital